Mifepristone

Distribution of medication for self-managed abortion from sources outside of formal health care settings increased 6 months after the Dobbs decision, despite state-level bans and restrictions, according to findings published in JAMA.

Since the Dobbs decision in June 2022, mifepristone has been heavily discussed within legal landscapes regarding its safety, efficacy and availability for women seeking medication abortion.

Hypercortisolism is prevalent among nearly one-quarter of people with difficult-to-control type 2 diabetes enrolled in a prospective phase 4 study, according to an industry press release.

Telemedicine requests for advance provision of abortion medications increased following Dobbs and FDA mifepristone rulings, according to study results published in JAMA Internal Medicine.

The overall incidence rate of abortions reimbursed through commercial insurance decreased 14% during the early stage of the COVID-19 pandemic despite eased regulations, and it did not return to pre-pandemic levels, a recent study found.

The 5th U.S. Circuit Court of Appeals has ruled to roll back mifepristone regulations, ending availability via telehealth or mail. However, these restrictions will not go into effect unless they are upheld by the U.S. Supreme Court.

The 5th U.S. Circuit Court of Appeals ruled on restrictions on the abortion drug mifepristone, but this ruling will not go into effect unless it is upheld by the U.S. Supreme Court.

Women who attempted self-managed medication abortion from 9 to 16 weeks gestation experienced high completion rates, with 23.5% visiting health care professionals to confirm completion or treat complications, researchers reported.

Use of mifepristone 10 mg daily resulted in significant symptom remission in adenomyosis and may be a treatment option for this patient population, according to study findings.

Obstetrics and gynecology residency programs at institutions and in states with abortion restrictions were less likely to incorporate patient factors when diagnosing early pregnancy loss, researchers reported.